From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

Fortunately, since my diagnosis of Sjogren's disease, there have been important efforts to rein in these middlemen who drive up costs for ... insurance companies manage claims and lower patient drug ...

The review of Minnesota-based Optum’s business practices by the Mississippi Board of Pharmacy indicated that the company paid independent pharmacies in Mississippi rates lower than chains and ...

Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...

Analyst reactions to Donald Trump’s election victory were mixed Wednesday, with potential positives including an FTC that is ...

It is all over bar the shouting win for the US election, with Donald Trump set to claim the Presidency, potentially with the ...

The owner of one of the three largest pharmacy middlemen in the United States last month filed suit to quash an attempt by the Federal Trade Commission to investigate industry ...

Despite reports this fall that the two payers had reopened merger talks, Cigna plans to use excess cash to buy back its ...

Huge health conglomerates have another reason to worry that their business model might be disrupted. On a visit to Columbus Monday, one of the country’s top antitrust watchdogs said her agency is ...

Bristol Myers Squibb reported third-quarter earnings and revenue that blew past expectations on strong sales from its blood ...

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...